Non-small cell lung cancer

You have access
Identification of Plasma Protein Biomarkers for Predicting Lung Cancer
KI SA SUNG, SANG JUN HAN, JIHYE LEE, MINSEOK KWON, DUK-HWAN KIM and YOUNG SUN OH

Anticancer Research November 2024, 44 (11) 5147-5155; DOI: https://doi.org/10.21873/anticanres.17340
You have access
Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung Cancer Xenograft Models
PO-JU LIN, YU-CHENG KUO, PO-WEI HU, WEI-LUNG CHEN, SHIH-CHIEH CHANG, FEI-TING HSU, JENG-YUAN WU and JIANN-HWA CHEN

Anticancer Research October 2024, 44 (10) 4327-4337; DOI: https://doi.org/10.21873/anticanres.17262
You have access
Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer
YOSHITO IMAMURA, TAKETO KATO, YUJI NOMATA, SHOJI OKADO, HIROKI WATANABE, YUTA KAWASUMI, KEITA NAKANISHI, YUKA KADOMATSU, HARUSHI UENO, SHOTA NAKAMURA, TETSUYA MIZUNO, TETSUNARI HASE, ICHIDAI TANAKA, MAKOTO ISHII, HIROSHI YATSUYA and TOYOFUMI FENGSHI CHEN-YOSHIKAWA

Anticancer Research August 2024, 44 (8) 3451-3461; DOI: https://doi.org/10.21873/anticanres.17165
You have access
Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer
WERONIKA ŚWITLIK, ZBIGNIEW WYŻEWSKI, KAROLINA GREGORCZYK-ZBOROCH, MARTA GIETLER, AGNIESZKA PUDLARZ, JOANNA SZEWIŃSKA, SŁAWOMIR ORZECHOWSKI, SŁAWOMIR JAKIEŁA and JANUSZ SZEMRAJ

Anticancer Research June 2024, 44 (6) 2445-2451; DOI: https://doi.org/10.21873/anticanres.17051
You have access
Upfront Multiplex Gene Test Helps Prolong Survival in Advanced Non-small Cell Lung Cancer
HIROKI KANASAKI, YUICHI OZAWA, NAOTO NAKAMURA, KIMIHIKO NAGASAKI, WATARU MATSUYAMA, DAISUKE AKAHORI, MITSURU NIWA, TAKASHI OGASAWARA and JUN SATO

Anticancer Research February 2024, 44 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.16863
You have access
Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer
SHUSUKE KURIHARA, RYOTA NAKAMURA, SATOSHI YONEYAMA, SHIHO TAKASE, TAKASHI HATORI, TETSUYA YAMAGISHI, TAKESHI NUMATA, KYOKO OTA, HIDETOSHI YANAI, TAKEO ENDO, YUKINORI INADOME, HIROAKI SATOH, RYO MUTO and KIYOSHI FUKUNAGA

Anticancer Research February 2024, 44 (2) 767-779; DOI: https://doi.org/10.21873/anticanres.16868
You have access
Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data
SARAH SHARMAN MOSER, LIOR APTER, JOSIE SOLOMON, GABRIEL CHODICK, MIRIANA WOLLNER and NAVA SIEGELMANN-DANIELI

Anticancer Research January 2024, 44 (1) 257-265; DOI: https://doi.org/10.21873/anticanres.16809
You have access
Sex Differences in Presentation, Treatment, and Survival in Patients Receiving Palliative (Chemo)Radiotherapy for Non-Small Cell Lung Cancer
CARSTEN NIEDER, SIV GYDA AANES, ASTRID DALHAUG and ELLINOR CHRISTIN HAUKLAND

Anticancer Research January 2024, 44 (1) 301-305; DOI: https://doi.org/10.21873/anticanres.16812
Open Access
Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma
SHIN ITO, KYOJI TSURUMI, NORIHISA SHINDO, SATOSHI SOMA, KAZUNORI YAMAGUCHI, KEIICHI TAMAI, MAI MOCHIZUKI, HARUNA FUJIMORI, MAMI MORITA, KANA WATANABE, AYA SUZUKI, TATSURO FUKUHARA and JUN YASUDA

Anticancer Research November 2023, 43 (11) 5031-5040; DOI: https://doi.org/10.21873/anticanres.16702
You have access
Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched Analysis
KYOTO MATSUDO, TOMOYOSHI TAKENAKA, ASATO HASHINOKUCHI, TAICHI NAGANO, FUMIHIKO KINOSHITA, SHINKICHI TAKAMORI, TAKAKI AKAMINE, MIKIHIRO KOHNO, NAOKO MIURA and TOMOHARU YOSHIZUMI

Anticancer Research November 2023, 43 (11) 5215-5222; DOI: https://doi.org/10.21873/anticanres.16723

Main menu

User menu

Search

Non-small cell lung cancer

Pages